Platelet function analyzer (PFA)-100® closure time in the evaluation of platelet disorders and platelet function

被引:300
作者
Hayward, CPM
Harrison, P
Cattaneo, M
Ortel, TL
Rao, AK
机构
[1] McMaster Univ, Med Ctr, Hamilton Hlth Sci Corp, Hamilton, ON L8N 3Z5, Canada
[2] Hamilton Reg Lab Med Program, Hamilton, ON, Canada
[3] Churchill Hosp, Oxford Haemophilia Ctr, Oxford OX3 7LJ, England
[4] Churchill Hosp, Thrombosis Unit, Oxford OX3 7LJ, England
[5] Univ Milan, DMCO, Osped San Paolo, Unita Ematol & Trombois, Milan, Italy
[6] Duke Univ, Med Ctr, Durham, NC USA
[7] Temple Univ, Sol Sherry Thrombosis Res Ctr, Sch Med, Philadelphia, PA 19140 USA
关键词
D O I
10.1111/j.1538-7836.2006.01771.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Closure time (CT), measured by platelet function analyzer (PFA-100((R))) device, is now available to the clinical laboratory as a possible alternative or supplement to the bleeding time test. Aim: On behalf of the Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (ISTH-SSC), a working Group was formed to review and make recommendations on the use of the PFA-100 CT in the evaluation of platelet function within the clinical laboratory. Methods: The Medline database was searched to review the published information on the PFA-100 CT in the evaluation of platelet disorders and platelet function. This information, and expert opinion, was used to prepare a report and generate consensus recommendations. Results: Although the PFA-100 CT is abnormal in some forms of platelet disorders, the test does not have sufficient sensitivity or specificity to be used as a screening tool for platelet disorders. A role of the PFA-100 CT in therapeutic monitoring of platelet function remains to be established. Conclusions: The PFA-100 closure time should be considered optional in the evaluation of platelet disorders and function, and its use in therapeutic monitoring of platelet function is currently best restricted to research studies and prospective clinical trials.
引用
收藏
页码:312 / 319
页数:8
相关论文
共 94 条
[31]   Screening for von Willebrand disease with a new analyzer using high shear stress: A study of 60 cases [J].
Fressinaud, E ;
Veyradier, A ;
Truchaud, F ;
Martin, I ;
Boyer-Neumann, C ;
Trossaert, M ;
Meyer, D .
BLOOD, 1998, 91 (04) :1325-1331
[32]   Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates [J].
Fressinaud, E ;
Veyradier, A ;
Sigaud, M ;
Boyer-Neumann, C ;
Le Boterff, C ;
Meyer, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (03) :777-783
[33]   Platelet function predicts myocardial damage in patients with acute myocardial infarction [J].
Frossard, M ;
Fuchs, I ;
Leitner, JM ;
Hsieh, K ;
Vlcek, M ;
Losert, H ;
Domanovits, H ;
Schreiber, W ;
Laggner, AN ;
Jilma, B .
CIRCULATION, 2004, 110 (11) :1392-1397
[34]   Monitoring of clopidogrel action: Comparison of methods [J].
Geiger, J ;
Teichmann, L ;
Grossmann, R ;
Aktas, B ;
Steigerwald, U ;
Walter, U ;
Schinzel, R .
CLINICAL CHEMISTRY, 2005, 51 (06) :957-965
[35]   Brief communication: Duration of platelet dysfunction after a 1-day course of ibuprofen [J].
Goldenberg, NA ;
Jacobson, L ;
Manco-Johnson, MJ .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (07) :506-509
[36]   Platelet function under aspirin, clopidogrel, and both after ischemic stroke - A case-crossover study [J].
Grau, AJ ;
Reiners, S ;
Lichy, C ;
Buggle, F ;
Ruf, A .
STROKE, 2003, 34 (04) :849-854
[37]   Profile and prevalence of aspirin resistance in patients with cardiovascular disease [J].
Gum, PA ;
Kottke-Marchant, K ;
Poggio, EC ;
Gurm, H ;
Welsh, PA ;
Brooks, L ;
Sapp, SK ;
Topol, EJ .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (03) :230-235
[38]   Hermansky-Pudlak syndrome: infrequent bleeding and first report of Turkish and Pakistani kindreds [J].
Harrison, C ;
Khair, K ;
Baxter, B ;
Russell-Eggitt, I ;
Hann, I ;
Liesner, R .
ARCHIVES OF DISEASE IN CHILDHOOD, 2002, 86 (04) :297-301
[39]   The role of PFA-100® testing in the investigation and management of haemostatic defects in children and adults [J].
Harrison, P .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 130 (01) :3-10
[40]   The PFA-100®:: a potential rapid screening tool for the assessment of platelet dysfunction [J].
Harrison, P ;
Robinson, M ;
Liesner, R ;
Khair, K ;
Cohen, H ;
Mackie, I ;
Machin, S .
CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (04) :225-232